Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with substantial heterogeneity in its clinical presentation. This makes diagnosis and effective treatment difficult, so better tools for estimating disease progression are needed. Here, we report results from the DREAM-Phil Bowen ALS Prediction Prize4Life challenge.
Data sources. In this study we used three datasets from the DREAM5 (D5) competition [28] and one additional dataset from the M3D database [37] (Table 1). DREAM5 was a blinded GRN inference challenge in which the participants inferred the underlying network using the microarray expression data. The data consists of expression profiles of genes measured in different experimental conditions such as drug, environmental and gene perturbations, or a combination of them.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.